BOC Sciences Blog

Can Peptides Replace DNA and Contribute to the Encoded Compound Library?

Can Peptides Replace DNA and Contribute to the Encoded Compound Library?

In addition to DNA, peptides, as amino acid polymers, have great potential for information storage (Figure 1A). Recently, Stephen L. Buchwald and Bradley L. Pentelute of Massachusetts Institute of Technology (MIT) […]

drug development

Casein Kinase 1 (CK1) Family as a Potential Therapeutic Target

CK1 functions Protein phosphorylation mediated by protein kinases is essential for the activation and deactivation of many signaling pathways in cells. As a result, abnormal protein kinase activity is frequently […]

Microglia Partner With T Cells To Cause Neurodegeneration, a New Nature Publication Discovers

Microglia Partner With T Cells To Cause Neurodegeneration, a New Nature Publication Discovers

Alzheimer’s disease (AD) is a complicated thing. Although amyloid-β (Aβ) is still considered to be the key to the pathogenesis of AD, which is supported by considerable evidence, the progression of […]

Review of Targeted Protein Degradation (TPD) Technology

Review of Targeted Protein Degradation (TPD) Technology

Targeted protein degradation (TPD) technology has been developed rapidly in recent years, especially proteolysis targeting chimeras (PROTACs). To date, a large number of degraders have been discovered against more than […]

Small Molecule Drug Design Virtual Screening

Virtual Screening Strategies for Small Molecule Drug Design

Drug screening is the initial link and key to drug development. In the past, traditional drug screening methods such as animal models were often costly and time-consuming. With the development […]

ADCs Make Their Mark in HER-Positive Cancers

ADCs Make Their Mark in HER-Positive Cancers

Members of the human epidermal growth factor receptor (HER) family, including HER1 (EGFR), HER2, HER3, and HER4, play central roles in regulating cell proliferation, survival, differentiation, and migration. Overexpression of […]

Therapeutic Opportunities and Challenges for Lipogenesis Inhibitor Development

Therapeutic Opportunities and Challenges for Lipogenesis Inhibitor Development

Fatty acids are essential for cell survival and function as biological energy substrates, structural components, and signaling molecules. Given their critical role, cells have evolved mechanisms to produce fatty acids from […]

drug R&D

Small Molecule Targeted Cancer Immunotherapy Draws the New Roadmap for Cancer Treatment

As an alternative to surgery, radiotherapy, and chemotherapy, tumor therapy via the immune pathway has made significant advances in recent years. Among the targeted drugs of immuno-oncology (IO), Ab drugs […]

drug development

Make the Future of Integrin Targeted Cancer Therapeutics Brighter

Integrins are cell adhesion and signaling proteins that play important roles in a wide range of biological functions. Currently, integrin-targeting drugs have been extensively developed in areas including cardiovascular disease, […]

PARP1 structure and function

Beyond PARP1 Single-Target Inhibitors–Combined Therapy Reveals More Possibilities

In late 2014, the PARP inhibitor Olaparib was approved to treat ovarian cancer with BRCA mutations. Since then, research in the field of PARP has received extensive attention, especially in […]